Hypersensitive C-reactive protein-albumin ratio in endovascular treatment of acute ischaemic stroke clinical prognostic value
Journal of the Pakistan Medical Association · 2025
DOI: 10.47391/jpma.21269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, 2025. Verfasst von Youde Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School, Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: C-Reactive Protein, Serum Albumin, Endovascular Procedures, Ischemic Stroke. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Objective
To determine the specific quantitative relationship between the hypersensitive C-reactive protein-albumin ratio and short-term clinical outcome measures within 30 days of endovascular therapy in patients diagnosed with acute ischaemic stroke.
Method
The retrospective study was conducted at the Jinyang Hospital, China, and comprised data from January 2019 to July 2023 of patients with acute large-vessel occlusive stroke who underwent endovascular therapy. The patients were stratified into two prognostic groups according to their 30-day postoperative modified Rankin Scale scores. Group A had patients with score 0-2 indicating good prognosis, and group B had patients with score 3-6 indicating poor prognosis. Baseline characteristics, vascular risk factors, laboratory test parameters, consultation duration, stroke subtype, responsible vessel and other relevant clinical data was noted and compared between the groups. Data was analysed using SPSS 25.
Results
Of the 195 patients, 125(64%) were males and 70(36%) were females. The overall median age was 65 years (interquartile range: 54-74 years). There were 102(52.3%) patients in group A and 93(47.7%) were in group B. Advanced age, hypertension, cerebral oedema, haemorrhagic transformation, baseline National Institutes of Health Stroke score, white blood cell count, infarct volume and hypersensitive C-reactive protein-albumin ratio were significantly different between the groups (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Graduate School, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- Department of Neurology, The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China.
- Cardiovascular Disease Centre, Baiyun Hospital of Guizhou Medical University, Guiyang, China.
- Clinical Research Centre, Guizhou Provincial Orthopaedic Hospital, Guiyang, China.
- Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- Graduate School, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Zitieren
APA
Cai, Y., Peng, Z., Zheng, X., Gan, F., He, Q., & Chen, Y. (2025). Hypersensitive C-reactive protein-albumin ratio in endovascular treatment of acute ischaemic stroke clinical prognostic value. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.21269
Vancouver
Cai Y, Peng Z, Zheng X, Gan F, He Q, Chen Y. Hypersensitive C-reactive protein-albumin ratio in endovascular treatment of acute ischaemic stroke clinical prognostic value. Journal of the Pakistan Medical Association. 2025. doi:10.47391/jpma.21269
BibTeX
@article{Cai2025,
author = {Cai, Youde and Peng, Zhongyong and Zheng, Xiong and Gan, Fang and He, Qiansong and Chen, Yunzhi},
title = {Hypersensitive C-reactive protein-albumin ratio in endovascular treatment of acute ischaemic stroke clinical prognostic value},
journal = {Journal of the Pakistan Medical Association},
year = {2025},
doi = {10.47391/jpma.21269}
}
EUVIMED